Marc McConnell, the Company's President, CEO, and Chairman, reports, "We are pleased to report that the marked improvement we saw at the outset of our fiscal year continued into the second quarter, ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results